Skip to main content
. 2014 Aug 2;140(2):462–469. doi: 10.1093/toxsci/kfu080

FIG. 2.

FIG. 2.

Chemical structures of the Nrf2 inducers used in this study. (A) Chemical structures of BARD, SUL and DMF, Nrf2 inducers that have entered the clinic. (B) Chemical structures of TP analogues of BARD.